🇺🇸 FDA
Patent

US 10434063

Implant compositions for the unidirectional delivery of therapeutic compounds to the brain

granted A61KA61K31/155A61K31/198

Quick answer

US patent 10434063 (Implant compositions for the unidirectional delivery of therapeutic compounds to the brain) held by The Board of Regents of the University of Texas System expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/155, A61K31/198, A61K31/282, A61K31/337